234 related articles for article (PubMed ID: 1261166)
1. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Rane A; Höjer B; Wilson JT
Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine 10,11-epoxide in children.
Rylance GW; Edwards C; Gard PR
Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
Furlanut M; Montanari G; Bonin P; Casara GL
J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
[TBL] [Abstract][Full Text] [Related]
5. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Friis ML; Christiansen J; Hvidberg EF
Eur J Clin Pharmacol; 1978 Nov; 14(1):47-51. PubMed ID: 729606
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
[TBL] [Abstract][Full Text] [Related]
7. Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy.
Schoeman JF; Elyas AA; Brett EM; Lascelles PT
Dev Med Child Neurol; 1984 Dec; 26(6):756-64. PubMed ID: 6440825
[TBL] [Abstract][Full Text] [Related]
8. Developmental and therapeutic pharmacology of antiepileptic drugs.
Miura H
Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
[TBL] [Abstract][Full Text] [Related]
9. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.
Korinthenberg R; Haug C; Hannak D
Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094
[TBL] [Abstract][Full Text] [Related]
10. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Brodie MJ; Forrest G; Rapeport WG
Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
13. Altered ratio of carbamazepine-10,11-epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction.
Schoeman JF; Elyas AA; Brett EM; Lascelles PT
Dev Med Child Neurol; 1984 Dec; 26(6):749-55. PubMed ID: 6440824
[TBL] [Abstract][Full Text] [Related]
14. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Bourgeois BF; Wad N
Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine, carbamazepine-10,11-epoxide and phenytoin concentrations in brain tissue of epileptic children.
Friis ML; Christiansen J
Acta Neurol Scand; 1978 Aug; 58(2):104-8. PubMed ID: 707037
[TBL] [Abstract][Full Text] [Related]
18. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
van Belle G; Friel PN
Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
Liu H; Delgado MR
Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents.
Rambeck B; Sälke-Treumann A; May T; Boenigk HE
Eur Neurol; 1990; 30(2):79-83. PubMed ID: 2111243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
